Bal Pharma has informed that it submitted to the exchange the disclosure of related party transactions on consolidated basis for the half year ended 30/09/2021 drawn as per IND (AS) 18 (Related Party Disclosures) format.
The above information is a part of company’s filings submitted to BSE.